Teresa DeLuca - May 19, 2022 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role
Director
Signature
/s/ Teresa DeLuca
Stock symbol
ATNF
Transactions as of
May 19, 2022
Transactions value $
$0
Form type
4
Date filed
5/23/2022, 04:30 PM
Previous filing
Mar 25, 2022
Next filing
May 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ATNF Common Stock 5K May 19, 2022 Direct
holding ATNF Common Stock 2.5K May 19, 2022 By Trust F1
holding ATNF Common Stock 2.5K May 19, 2022 By Trust F2
holding ATNF Common Stock 2.5K May 19, 2022 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATNF Non-Qualified Stock Option (right to buy) Award $0 +21K $0.00 21K May 19, 2022 Common Stock 21K $1.36 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are held by The Santina Iraggi Irrvoc TR, U/A 11/2/20, an irrevocable trust, of which the Reporting Person is beneficiary and trustee.
F2 Shares are held by the REV TR FBO Teresa M Deluca, a revocable trust, of which the Reporting Person is beneficiary and trustee.
F3 Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
F4 The Options vest at the rate of 1/39th of such options ratably on a monthly basis over the 39 months following the grant date, on the last day of each calendar month (beginning on May 31, 2022), subject to the holder's continued service to the Company.